pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Pharma gifts and payments to doctors linked to higher inappropriate prescribing, study finds

Oct 9, 2026·read at STAT ↗Negative

A Cochrane review of dozens of prior studies found that gifts and payments from drug makers to physicians lead to more inappropriate prescribing and a higher total number of prescriptions, which likely drives up health‑care costs.

Pharmaceutical advertising or educational activities directed at doctors showed a similar pattern, increasing both the volume of prescriptions written and their overall cost.

Conversely, policies that restrict or manage financial interactions between companies and physicians were linked to improved prescribing behaviour.

The authors also reported that evidence was insufficient to draw firm conclusions about the effect of free drug samples and other promotional tactics on the choice of specific drugs in hospital settings.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds”

read at STAT ↗
506 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2RISING2LILLY
drugs
Obesity2Cancer ProgramKEYTRUDApembrolizumab
topics
Obesity2

related stories

  • 2d ago5 biggest venture capital raises of Q3 2026BioSpace
  • 4h agoSTAT+: Up and down the ladder: The latest comings and goingsSTAT
  • Sep 286 immunology targets to sustain a mammoth I&I marketBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech